Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Assets Average: 2011-2025

Historic Assets Average for Lifecore Biomedical (LFCR) over the last 13 years, with May 2025 value amounting to $238.5 million.

  • Lifecore Biomedical's Assets Average fell 4.63% to $238.5 million in Q2 2025 from the same period last year, while for May 2025 it was $238.5 million, marking a year-over-year decrease of 4.63%. This contributed to the annual value of $246.7 million for FY2025, which is 2.80% down from last year.
  • Lifecore Biomedical's Assets Average amounted to $238.5 million in Q2 2025, which was down 3.25% from $246.5 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Assets Average ranged from a high of $504.4 million in Q2 2021 and a low of $238.5 million during Q2 2025.
  • For the 3-year period, Lifecore Biomedical's Assets Average averaged around $247.9 million, with its median value being $248.1 million (2023).
  • As far as peak fluctuations go, Lifecore Biomedical's Assets Average climbed by 19.58% in 2021, and later plummeted by 42.84% in 2022.
  • Lifecore Biomedical's Assets Average (Quarterly) stood at $433.0 million in 2021, then crashed by 37.38% to $271.2 million in 2022, then dropped by 9.39% to $245.7 million in 2023, then rose by 2.19% to $251.1 million in 2024, then dropped by 4.63% to $238.5 million in 2025.
  • Its last three reported values are $238.5 million in Q2 2025, $246.5 million for Q1 2025, and $251.1 million during Q4 2024.